Peptides and related molecules that bind to TALL-1
The present invention concerns therapeutic agents that modulate the activity of TALL-1. In accordance with the present invention, modulators of TALL-1 may comprise an amino acid sequence Dz 2 Lz 4 wherein z 2 is an amino acid residue and z 4 is threonyl or isoleucyl. Exemplary molecules comprise a sequence of the formulae (SEQ. ID. NO: 100) a 1 a 2 a 3 CDa 6 La 8 a 9 a 10 Ca 12 a 13 a 14 , (SEQ. ID. NO: 104) b 1 b 2 b 3 Cb 5 b 6 Db 8 Lb 10 b 11 b 12 b 13 b 14 Cb 16 b 17 b 18 (SEQ. ID. NO: 105) c 1 c 2 c 3 Cc 5 Dc 7 Lc 9 c 10 c 11 c 12 c 13 c 14 Cc 16 c 17 c 18 (SEQ. ID. NO: 106) d 1 d 2 d 3 Cd 5 d 6 d 7 WDd 10 Ld 13 d 14 d 15 Cd 16 d 17 d 18 (SEQ. ID. NO: 107) e 1 e 2 e 3 Ce 5 e 6 e 7 De 9 Le 11 Ke 13 Ce 15 e 16 e 17 e 18 (SEQ. ID NO: 109) f 1 f 2 f 3 Kf 5 Df 7 Lf 9 f 10 Qf 12 f 13 f 14 wherein the substituents are as defined in the specification. The invention further comprises compositions of matter of the formula (X 1 ) a -V 1 -(X 2 ) b wherein V 1 is a vehicle that is covalently attached to one or more of the above TALL-1 modulating compositions of matter. The vehicle and the TALL-1 modulating composition of matter may be linked through the N- or C-terminus of the TALL-1 modulating portion. The preferred vehicle is an Fc domain, and the preferred Fc domain is an IgG Fc domain.
1. A TALL-1-binding composition of matter comprising an amino acid sequence of the formula
f 1 f 2 f 3 Kf 5 Kf 7 Lf 9 f 10 Qf 12 f 13 f 14 (SEQ ID NO: 109)
wherein:
f 1 , f 2 , and f 3 are absent or are amino acid residues;
f 5 is W;
f 7 is an amino acid residue;
f 9 is T or I;
f 10 is K, R, or H;
f 12 is C, a neutral hydrophobic residue, or a basic residue;
f 13 is C, a neutral hydrophobic residue or is absent; and
f 14 is any amino acid residue or is absent;
provided that only one of f 1 , f 2 , and f 3 may be C, and only one of f 12 , f 13 , and f 14 may be C.
2. A composition of matter of claim 1 , wherein f 7 is L.
3. A composition of matter of claim 1 , wherein f 9 is T.
4. A composition of matter of claim 1 , wherein f 10 is K.
5. A composition of matter of claim 1 , wherein f 12 is C and one of f 1 , f 2 , and f 3 is C.
6. A composition of matter of claim 1 , wherein f 13 is V.
7. A composition of matter of claim 1 comprising an amino acid sequence of the formula
f 1 f 2 f 3 KWDf 7 Lf 9 KQf 12 f 13 f 14 (SEQ ID NO: 125).
8. A TALL-1-binding composition of matter comprising an amino acid sequence selected from the group consisting of SEQ ID NOS: 32, 33, 58, 60, 63, 66, 67, 69, 114, 115, 122, 123, 124, 147–150, 152–177, 179, 180, and 187.
9. A composition of matter of claim 8 comprising an amino acid sequence of the formula
LPGCKWDLLIKQWVCDPL (SEQ ID NO: 33).